- Home
- HOTH vs APTO Comparison
HOTH vs APTO Comparison
Compare HOTH & APTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOTH
- APTO
- Stock Information
- Founded
- HOTH 2017
- APTO 1986
- Country
- HOTH United States
- APTO Canada
- Employees
- HOTH N/A
- APTO N/A
- Industry
- HOTH Biotechnology: Pharmaceutical Preparations
- APTO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HOTH Health Care
- APTO Health Care
- Exchange
- HOTH Nasdaq
- APTO Nasdaq
- Market Cap
- HOTH 8.3M
- APTO 6.8M
- IPO Year
- HOTH 2019
- APTO N/A
- Fundamental
- Price
- HOTH $0.98
- APTO $1.71
- Analyst Decision
- HOTH Strong Buy
- APTO Strong Buy
- Analyst Count
- HOTH 4
- APTO 3
- Target Price
- HOTH $4.75
- APTO $112.00
- AVG Volume (30 Days)
- HOTH 623.8K
- APTO 58.8K
- Earning Date
- HOTH 05-13-2025
- APTO 05-13-2025
- Dividend Yield
- HOTH N/A
- APTO N/A
- EPS Growth
- HOTH N/A
- APTO N/A
- EPS
- HOTH N/A
- APTO N/A
- Revenue
- HOTH N/A
- APTO N/A
- Revenue This Year
- HOTH N/A
- APTO N/A
- Revenue Next Year
- HOTH N/A
- APTO N/A
- P/E Ratio
- HOTH N/A
- APTO N/A
- Revenue Growth
- HOTH N/A
- APTO N/A
- 52 Week Low
- HOTH $0.58
- APTO $1.35
- 52 Week High
- HOTH $3.80
- APTO $50.10
- Technical
- Relative Strength Index (RSI)
- HOTH 42.23
- APTO 26.12
- Support Level
- HOTH $1.01
- APTO $3.20
- Resistance Level
- HOTH $1.19
- APTO $3.43
- Average True Range (ATR)
- HOTH 0.07
- APTO 0.35
- MACD
- HOTH -0.01
- APTO -0.06
- Stochastic Oscillator
- HOTH 23.82
- APTO 13.69
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.
About APTO Aptose Biosciences Inc.
Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The Company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.